Financial News
Press Releases about Amneal Pharmaceuticals Inc
Amneal Reports Second Quarter 2022 Financial Results
August 05, 2022
Via Business Wire
Amneal Appoints Deborah M. Autor to Board of Directors
August 03, 2022
Via Business Wire
Amneal Reports First Quarter 2022 Financial Results
May 04, 2022
Via Business Wire
Amneal to Report First Quarter 2022 Results on May 4, 2022
April 07, 2022
Via Business Wire
Amneal Expands Injectables Portfolio with 4 New Products
February 17, 2022
Via Business Wire
Via Business Wire
Amneal Acquires Saol Therapeutics’ Baclofen Franchise
January 05, 2022
Via Business Wire
Amneal Receives Approval for Difluprednate Ophthalmic Emulsion
November 19, 2021
Via Business Wire
Amneal to Virtually Participate at Upcoming Investor Conferences
November 12, 2021
Via Business Wire
Amneal Reports Third Quarter 2021 Financial Results
November 03, 2021
Via Business Wire
Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA
October 27, 2021
Via Business Wire
Amneal to Report Third Quarter 2021 Results on November 3, 2021
October 06, 2021
Via Business Wire
Amneal Reports Second Quarter 2021 Financial Results
August 09, 2021
Via Business Wire
Amneal Receives Approval for Generic TobraDex®
July 19, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.